Fig. 1From: The relationship between retroperitoneal lymphadenectomy and survival in advanced ovarian cancer patients(a) Overall survival (OS) and (b) progression-free survival (PFS) in patients with or without systematic retroperitoneal lymphadenectomy, confining analysis to patients with no gross residual disease and residual disease < 1 cmBack to article page